MedTrace Logo

Safety and Performance of the CAVU Medical, Inc. Attune Tubing Study

NCT01422941 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2015-07-28

No results posted yet for this study

Summary

The objectives of this clinical research project are to demonstrate the safety and feasibility of CAVU Medical, Inc.'s Attune Device.

Conditions

Interventions

DEVICE

CAVU Attune Device

The CAVU Attune device is used with LAGB.

Sponsors & Collaborators

  • Cavu Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • Anthony Brancatisano, B Appl Sc · Institute of Weight Control

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2011-06-30

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01422941 on ClinicalTrials.gov